MNBRX
Price
$20.64
Change
+$0.05 (+0.24%)
Updated
Oct 17 closing price
Net Assets
506.86M
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

MNBRX vs RLEFX

Header iconMNBRX vs RLEFX Comparison
Open Charts MNBRX vs RLEFXBanner chart's image
Manning & Napier Pro-Blend Extnd Term R
Price$20.64
Change+$0.05 (+0.24%)
VolumeN/A
Net Assets506.86M
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
MNBRX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
MNBRX vs. RLEFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNBRX is a Hold and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. MNBRX (507M). RLEFX pays higher dividends than MNBRX: RLEFX (1.92) vs MNBRX (1.62). MNBRX was incepted earlier than RLEFX: MNBRX (15 years) vs RLEFX (10 years). MNBRX (1.27) is less costly to investors than RLEFX (0.39). MNBRX is a more actively managed with annual turnover of: 71.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than MNBRX: RLEFX (250) vs MNBRX (2000). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. MNBRX (2.37). RLEFX return over 5 years is better than : 43.26 vs. MNBRX (-0.51).
MNBRXRLEFXMNBRX / RLEFX
Total Expense Ratio1.270.39326%
Annual Report Gross Expense Ratio1.270.39326%
Fund Existence15 years10 years-
Gain YTD6.99814.81947%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets507M265B0%
Annual Yield % from dividends1.621.9284%
Returns for 1 year2.378.9426%
Returns for 3 years27.8851.3954%
Returns for 5 years-0.5143.26-1%
Returns for 10 years11.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc